Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 187 of the 193 references it cites were found in a registry or an index; 82 of the 198 sources its claims cite were checked for support.

Lactic Acid Bacteria Exopolysaccharides Producers: A Sustainable Tool for Functional Foods

Open access

Abstract

Lactic acid bacteria (LAB) used in the food industry, mainly for the production of dairy products, are able to synthetize exopolysaccharides (EPS). EPS play a central role in the assessment of rheological and sensory characteristics of dairy products since they positively influence texture and organoleptic properties. Besides these, EPS have gained relevant interest for pharmacological and nutraceutical applications due to their biocompatibility, non-toxicity and biodegradability. These bioactive compounds may act as antioxidant, cholesterol-lowering, antimicrobial and prebiotic agents. This review provides an overview of exopolysaccharide-producing LAB, with an insight on the factors affecting EPS production, their dairy industrial applications and health benefits.

Overview

CoChat Summary

## TL;DR

This review summarizes how lactic acid bacteria produce exopolysaccharides (EPS), what controls their synthesis, and why they matter for fermented foods and health. It argues that EPS can improve texture and may offer antioxidant, cholesterol-lowering, antibacterial, and prebiotic benefits, but industrial use is still limited by low yields and a lack of in vivo/human validation.

## Key findings

  • EPS from LAB improve dairy product properties by increasing viscosity, texture, stability, mouth-feel, and reducing syneresis; in yogurt, EPS-producing *S. thermophilus* and *Lb. delbrueckii* subsp. *bulgaricus* can produce a smoother, creamier texture and serve as an alternative to stabilizers.
  • Reported EPS yields are usually under 1 g/L for most strains under non-optimized conditions, with examples including *Lim. fermentum* (0.75–0.85 g/L), *Lev. brevis* (0.35 g/L), *Lpb. plantarum* (0.14–0.4 g/L), and *Lact. lactis* (0.2–0.35 g/L); higher yields were reported for *Lim. reuteri* L26 and DSM 17938 (4.3–5 g/L) and *Lpb. plantarum* BR2 (2.8 g/L).
  • The review reports bioactivity examples: *Lpb. plantarum* C88 EPS scavenged ROS and inhibited lipid peroxidation; *Lpb. plantarum* RJF4 EPS reduced cholesterol by 42.24%, *Lpb. plantarum* BR2 by 45%, and *Lcb. paracasei* M7 by 70.78% in vitro; *Lcb. paracasei* M7 EPS also inhibited biofilms against several species by 58.88%–64.27%.
  • A notable prebiotic finding was that two EPS fractions from *Lb. delbrueckii* ssp. *bulgaricus* SRFM-1 promoted bifidobacteria, lactobacilli, and lactococci and produced high short-chain fatty acid levels in an in vitro digestion/fermentation study.

## Methods

  • Narrative review of prior literature on LAB EPS, covering biosynthesis pathways, genetics, screening, isolation/purification, quantification/characterization, health effects, and dairy applications.
  • The paper synthesizes evidence from in vitro studies, some in vivo animal studies, and industrial/technological reports; it does not present new experimental data.
  • Main analysis is descriptive and comparative: it summarizes reported EPS yields, production conditions, structural features, and functional outcomes across strains and applications.

## Limitations

  • The paper explicitly states that industrial use of EPS is still limited by high production costs, low in situ EPS production, and the need to reduce costs and improve yields using approaches such as waste biomass, better fermentation, and improved downstream recovery.
  • It explicitly notes that in vivo studies are still limited and that more in vivo and clinical studies are needed to validate EPS as functional adjuncts.
  • Evident from the text: prebiotic effects are mostly supported by in vitro digestion/fermentation models, and the paper states that no human intervention studies have been performed to date.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/foods10071653

Cites

187 of 187 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Classification of HoPS. The majority of HoPS-producing LAB produce a single glycansucrase enzyme, but some contain more than one glycansucrase gene and therefore may synthesize more than one type of HoPS.
Figure 1 Classification of HoPS. The majority of HoPS-producing LAB produce a single glycansucrase enzyme, but some contain more than one glycansucrase gene and therefore may synthesize more than one type of HoPS.CC BY · PubMed Central
Figure 2 HePS production via Wzy-dependent pathway.
Figure 2 HePS production via Wzy-dependent pathway.CC BY · PubMed Central
Figure 3 Principal health benefits of EPS produced by LAB strains. Graphical illustrations were created by using some graphical items from Servier Medical Art by Servier, available on https://smart.servier.com/ (accessed on 15 January 2021) under a Creative Commons Attribution 3.0 Unported License.
Figure 3 Principal health benefits of EPS produced by LAB strains. Graphical illustrations were created by using some graphical items from Servier Medical Art by Servier, available on https://smart.servier.com/ (accessed on 15 January 2021) under a Creative Commons Attribution 3.0 Unported License.CC BY · PubMed Central

Verification

Claims the paper makes

53 Valid · 10 Not valid · 74 Not checked · 29 Own results and interpretations

83 more claims · 22 with their cited sources checked

Create a free account to see all 166 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 42
  • It may state two separate claims as one. 55

Create a free account to see these claims.

Citations

Cites

Show all 193 references

Research works printed but not linked: 1

  1. Characklis, W.G., and Wilderer, P.A. (1989). The Structure and Function of Biofilms, Wiley.

Cited by

See all 194

Metadata

Authors
Prete, R., Alam, M. K., Perpetuini, G., Perla, C., Pittia, P., & Corsetti, A.
Affiliations
  • University of Teramo (IT)
  • Dalton Biotecnologie srl, Spoltore, 65010 Pescara, Italy
Corresponding author
Perpetuini, Giorgia
Venue
Foods
Publisher
MDPI AG
Published
2021-07-17
Volume
10
Issue
7
Pages
1653
ISSN
2304-8158 (ISSN-L)
OpenAlex
W3185713597
Cited by
194
References
193
Citations by year
2026: 38 · 2025: 45 · 2024: 44 · 2023: 40 · 2022: 24 · 2021: 2
FWCI
2.50
Type
journal article
Language
en
Open access
Locations
  • Foods (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UniTERAMO Research Catalog (University of Teramo) (submittedVersion)
Funders
“PON Ricerca e Innovazione 2014‐20,” azione I.1 “Dottorati innovativi con caratterizzazione industriale,” (not available)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Polysaccharides Composition and Applications
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Biopolymer Synthesis and Applications
Keywords
lactic acid bacteria, exopolysaccharides, functional foods, dairy products, rheology, sensory properties, nutraceuticals, antioxidant activity, cholesterol lowering, antimicrobial activity, prebiotics, biocompatibility, health benefits

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lactic Acid Bacteria Exopolysaccharides Producers: A Sustainable Tool for Functional Foods. https://app.cochat.ai/papers/10.3390/foods10071653
The paper
Prete, R., Alam, M. K., Perpetuini, G., Perla, C., Pittia, P., & Corsetti, A. (2021). Lactic Acid Bacteria Exopolysaccharides Producers: A Sustainable Tool for Functional Foods. Foods. https://doi.org/10.3390/foods10071653

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.